dc.contributorRodríguez, Francisco J.
dc.contributorRosenstiehl, Shirley
dc.creatorCarpio Rosso, Wuily
dc.creatorMeneses, Said
dc.creatorRodríguez, Francisco J.
dc.date.accessioned2022-02-05T20:22:19Z
dc.date.accessioned2022-09-22T14:38:53Z
dc.date.available2022-02-05T20:22:19Z
dc.date.available2022-09-22T14:38:53Z
dc.date.created2022-02-05T20:22:19Z
dc.identifierhttps://repository.urosario.edu.co/handle/10336/33571
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3440838
dc.description.abstractPurpose: To analyze the morphological characteristics of subretinal hyperreflective material (SHRM) and short-term visual outcomes in patients with neovascular age-related macular degeneration (nAMD) treated with anti-vascular endothelial grown factor (anti-VEGF) at the Fundacion Oftalmologica Nacional between 2011 and 2017. Methodology: Descriptive longitudinal study, including 65 patients with previously untreated nAMD, between January 2011 and December 2017. The structural optical coherence tomography (OCT) was reviewed to determine quantitative and qualitative characteristics of SHRM, and best corrected visual acuity (BCVA) in LogMAR before and after treatment. Results: The median age was 76 years (range 68-84). The majority of patients were women in 56.9%. The laterality of the most affected eye was the right in 50.8%. Aflibercept was the most widely used antiangiogenic in 40% of the patients. The median BCVA was 0.7 (range 0.5-1.2) logMAR and 0.7 (range 0.4-1) logMAR at baseline and after treatment, respectively. The baseline parameters with a positive correlation by bivariate analysis before and after treatment were the BCVA, reflectivity, edges and extension of the SHRM. The parameters that were associated with an improvement in BCVA after treatment were the presence of the ellipsoid zone (EZ) and external limiting membrane (ELM), reflectivity, homogeneity and extension of the SHRM. Conclusion: This study provides tomographic features of the SRHM associated with short-term visual outcomes in eyes with nAMD treated with anti-VEGF.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherEspecialización en Retina y Vítreo
dc.publisherEscuela de Medicina y Ciencias de la Salud
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.rightsRestringido (Temporalmente bloqueado)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.sourceJonas JB, Gemmy C, Panda-Jonas S. Updates on the Epidemiology of Age-Related Macular Degeneration. Asia-Pac J Ophthalmol. 2017;6:493–7.
dc.sourceT Eng K, Kertes PJ. Ranibizumab in neovascular age-related macular degeneration. Clin Interv Aging. 2006;1(4):451–66.
dc.sourceWong T, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, et al. The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration. A Systematic Review of the Literature and Meta-analysis. Ophthalmology. 2008;115(1):116–26.
dc.sourceShah VP, Shah SA, Mrejen S, Freund KB. Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration. Retina. 2014;34(7):1281–8.
dc.sourcePokroy R, Mimouni M, Barayev E, Segev F, Geffen N, Nemet A, et al. Prognostic value of subretinal hyperreflective material in neovascular age-related macular degeneration treated with bevacizumab. Retina. 2017;0(0):1–7.
dc.sourceWilloughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, et al. Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology. 2015;1–8.
dc.sourceCasalino G, Bandello F, Chakravarthy U. Changes in neovascular lesion hyperreflectivity after anti-VEGF treatment in age-related macular degeneration: An integrated multimodal imaging analysis. Invest Ophthalmol Vis Sci. 2016;57(9):288–98.
dc.sourceCharafeddin W, Nittala MG, Oregon A, Sadda SR. Relationship Between Subretinal Hyperreflective Material Reflectivity and Volume in Patients With Neovascular Age-Related Macular Degeneration Following Anti-Vascular Endothelial Growth Factor Treatment. Ophthalmic Surg Lasers Imaging Retin. 2015;46(5):523–30.
dc.sourceWong WL, Su X, Li X, Cheung CMG, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob Helath. 2014;2:e106–16.
dc.sourceGiani A, Esmaili DD, Luiselli C, Cigada M, Salvetti P, Miller JW, et al. Displayed reflectivity of choroidal neovascular membranes by optical coherence tomography correlates with presence of leakage by fluorescein angiography. Retina. 2011;31(5):942–8.
dc.sourceBhatt N, Diamond J, Jalali S, Das T. Choroidal Neovascular Membrane. Indian J Ophthalmol. 1998;46:67–80.
dc.sourceMichalewski J, Nawrocki J, Trebinska M, Michalewska Z. Spectral-domain optical coherence tomography features preceding new-onset neovascular membrane formation. Can J Ophthalmol. 2014;49(4):339–44.
dc.sourceEagle RC. Eye Pathology. Philadelphia USA: Wolters Kluwer / Lippincott Williams & Wilkins; 2011. 145–148 p.
dc.sourceCharles S. Choroidal Neovascular Membranes [Internet]. 2017. Available from: https://emedicine.medscape.com/article/1226568-overview#a6
dc.sourceBressler NM, Doan Q V, Varma R, Lee PP, Suñer IJ, Dolan C, et al. Estimated Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Choroidal Neovascularization. Arch Ophthalmol. 2011;129(6):709–17.
dc.sourceTortorella P, D’Ambrosio E, Iannetti L, De Marco F, La Cava M. Correlation between visual acuity, inner segment/outer segment junction, and cone outer segment tips line integrity in uveitic macular edema. Biomed Res Int. 2015;1–5.
dc.sourceArepalli S, Traboulsi EI, Ehlers JP. Ellipsoid Zone Mapping and Outer Retinal Assessment in Stargardt Disease. Retina. 2017;1–5.
dc.sourceOres R, Puche N, Querques G, Blanco-Garavito R, Merle B, Coscas G, et al. Gray hyper-reflective subretinal exudative lesions in exudative age-related macular degeneration. Am J Ophthalmol. 2014;158(2):354–61.
dc.sourceRoberts PK, Zotter S, Montuoro A, Pircher M, Baumann B, Ritter M, et al. Identification and quantification of the angiofibrotic switch in neovascular AMD. Invest Ophthalmol Vis Sci. 2019;60(1):304–11.
dc.sourceCasalino G, Stevenson MR, Bandello F, Chakravarthy U. Tomographic Biomarkers Predicting Progression to Fibrosis in Treated Neovascular Age-Related Macular Degeneration: A Multimodal Imaging Study. Ophthalmol Retin. 2017;2(5):451–61.
dc.sourceKumar JB, Stinnett S, Han JIL, Jaffe GJ. Correlation of Subretinal Hyperreflective Material Morphology and Visual Acuity in Neovascular Age-Related Macular Degeneration. Retina. 2019;(00):1–12.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectDegeneración macular relacionada con la edad
dc.subjectNeovascularización
dc.subjectTomografía de coherencia óptica
dc.subjectBiomarcadores
dc.subjectMaterial hiperreflectivo subretiniano
dc.titleCaracterización del material hiperreflectivo subretiniano en pacientes con degeneración macular relacionada con la edad neovascular tratados con antiangiogénicos
dc.typemasterThesis


Este ítem pertenece a la siguiente institución